News

Filter by Category

Filter by Program

Filter by Publish Date

Stakeholders Share Data to Design Better Trials for Neurodegenerative Diseases

The Coalition Against Major Diseases is pooling clinical data to build disease and drug models.

FDA approved rifampin for the treatment of tuberculosis (TB) in 1971, the same year Intel Corporation invented the first microproc

Re: the April 19 article “Vast study advances breast cancer fight.”

WASHINGTON–(BUSINESS WIRE)– The Association of Clinical Research Organizations (ACRO) today provided the FDA with a nu

The Critical path Institute (C-Path), the US Food and Drug Administration (FDA)-supported public-private initiative working to adv

Your doctor may soon – perhaps in a year – be able to order up a test to map out your entire genome, or genetic bluepr

I saw a presentation yesterday by Carolyn Compton, the new head of C-PATH, the critical path institute located in Tucson, AZ. This

Critical Path Institute (C-Path) has announced that Steven T. Broadbent has been chosen as the next chief operating officer of C-P

C-Path’s work was positively acknowledged by Dr. Janet Woodcock during the April 18 House Energy and Commerce Committee Hear